Expansion opportunities Elanco’s ongoing facility expansions and capacity increases (Elwood manufacturing upgrade and Kansas biologics expansion) signal heightened demand and potential opportunities to supply manufacturing equipment, facility services, contract manufacturing support, and GMP-compliant packaging solutions.

Integrated animal health platform Post-merger positioning as an independent global animal health leader creates cross-sell opportunities across vaccines, parasiticides, and livestock medications, with potential to bundle Elanco and Bayer Animal Health offerings for veterinary clinics, farms, and pet care channels.

Workforce and training Active workforce development partnerships and apprenticeship programs with Iowa Central indicate demand for training, onboarding support, digital learning platforms, and technical skills services that can be offered to customers and distributors to improve product adoption.

Digital and marketing stack Utilization of modern tech stack including Google Ads, The Trade Desk, AWS, and content management tools suggests opportunities to provide analytics, programmatic marketing services, digital onboarding experiences for veterinarians and retailers, and data-driven demand forecasting.

Financial and risk signals Recent revenue growth signals and a history of SEC-related penalties imply sensitivity to cost optimization, compliance tooling, and trusted financial services for customers and partners, highlighting a need for transparent value propositions, pricing strategies, and risk mitigation solutions.